|
Listings
Results 1 - 8 of 8
EGFR 7p12 AmplificationCategory:Oncology Test CodeF EGFR AssociationsBreast, lung and colon cancer MethodologyFluorescence in situ Hybridization (FISH) EGFR Mutation Comprehensive Analysis Exon 18-21 FeaturedCategory:Mutation Analysis Test CodeP EGFR AssociationsNSCLC,Non Small-cell Lung Cancer,Response to EGFR tyrosine kinase inhibitors; Gefitinib, Erlotinib, IRESSA, Tarceva Responsiveness in NSCLC MethodologyReal-time Polymerase chain reaction for exon 18-21. EGR1 -5/5q-Category:Myelodysplastic Syndrome (MDS) Test CodeF EGR1 Associations5q- syndrome, Myelodysplasia (MDS), Myeloproliferative disease (MPD), Acute myelogenous leukemia (AML) MethodologyFluorescence in situ Hybridization (FISH) Epidermal Growth Factor Receptors (HER1) by IHCCategory:Immunohistochemistry markers Test CodeI HER1 AssociationsPrognostic marker
Overexpressed in breast cancer, lung, brain, bladder, gastric, esophagus, cervix, ovary and endometrium.
MethodologyImmunohistochemistry
CONFIRMâ„¢ anti-Epidermal Growth Factor Receptor
(3C6) Primary Antibody. Epstein Barr Virus by In-Situ HybridizationCategory:Anatomic Pathology Test CodeI EBER ISH AssociationsInfectious mononucleosis, Burkitt's lymphoma,Reed Sternberg cells Hodgkin's lymphoma, nasopharyngeal carcinoma, HIV infection MethodologyChromogenic in-situ Hybridization (CISH) ERCC1, Excision Repair Cross Complementing PolypeptideCategory:Immunohistochemistry markers Test CodeI ERCC1 Associationsoxaliplatin response in colorectal cancer MethodologyImmunohistochemistry
Estrogen Progesterone Receptors by IHCCategory:Immunohistochemistry markers Test CodeI ERPR AssociationsBreast cancer MethodologyImmunohistochemistry
CONFIRMâ„¢ anti-Estrogen Receptor (clone SP1)Primary Antibody
CONFIRM anti-Progesterone Receptor (clone 1E2) Primary Antibody EWSR1 22q12 Rearrangement Ewing SarcomaCategory:Oncology Test CodeF EWSR1 AssociationsEwing sarcoma MethodologyFluorescence in situ Hybridization (FISH)
Results 1 - 8 of 8
|
Search DirectoryDirectory |